Work

Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.

Year: 2000

Type: article

Source: VUBIR (Vrije Universiteit Brussel)

Authors: Peter I. Croucher, C M Shipman, Mark Perry, J M Lippitt, Kewal Asosingh, van Beek Ejr., B Van Camp, R.G.G. Russell, Colin R. Dunstan, Karin Vanderkerken

Institution: Vrije Universiteit Brussel

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2512819668

FWCI: 0.185

Cites:

Cited by: 1

Related to: 10